Nonhormonal chemotherapy of tumors metastatic to bone.
D000230:Adenocarcinoma / Q000188:drug therapy; D000470:Alkaloids / Q000627:therapeutic use*; D000477:Alkylating Agents / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000963:Antimetabolites / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy; D005354:Fibrosarcoma / Q000188:drug therapy; D005492:Folic Acid / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009369:Neoplasms / Q000532:radiotherapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D012516:Osteosarcoma / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011687:Purines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012512:Sarcoma, Ewing / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000188:drug therapy; D014265:Triethylenemelamine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000188:drug therapy
D000470:Alkaloids; D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D009588:Nitrogen Mustard Compounds; D011687:Purines; D011743:Pyrimidines; D013852:Thiotepa; D005492:Folic Acid; D014265:Triethylenemelamine